Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
2021 · European Journal of Cancer · 86 citations
https://doi.org/10.1016/j.ejca.2021.06.033
J
Julius Emons
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
798
Citations
14
h-index
26
i10-index
Julius Emons is an academic researcher from Friedrich-Alexander-Universität Erlangen-Nürnberg. The author has contributed to research in topics: Digital Radiography and Breast Imaging & Radiomics and Machine Learning in Medical Imaging & Breast Cancer Treatment Studies. The author has an h-index of 14, co-authored 104 publications.
ORCID: 0000-0002-2520-4443Papers by this author
worksMammographic density and prognosis in primary breast cancer patients
2021 · The Breast · 18 citations
https://doi.org/10.1016/j.breast.2021.06.004
Breast MRI texture analysis for prediction of BRCA-associated genetic risk
2020 · BMC Medical Imaging · 15 citations
https://doi.org/10.1186/s12880-020-00483-2
Detection of Microcalcifications in Spiral Breast Computed Tomography with Photon-Counting Detector Is Feasible: A Specimen Study
2021 · Diagnostics · 13 citations
https://doi.org/10.3390/diagnostics11050848
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
2020 · Archives of Gynecology and Obstetrics · 12 citations
https://doi.org/10.1007/s00404-020-05525-2
Spatial expression of claudin 18.2 in matched primaries and metastases of tubo-ovarian carcinoma of all subtypes
2024 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 10 citations
https://doi.org/10.1007/s00428-024-03756-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat